As neural implant technology and A.I. advance at breakneck speeds, do we need a new set of rights to protect our most ...
Novel combination with neoadjuvant eftilagimod alfa (efti) achieves significant 51.5% tumour hyalinization/fibrosis across ...
Exploratory Phase 2 analysis shows Verrica’s novel oncolytic peptide, VP-315, reprograms the tumor microenvironment, ...
Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San ...
In the study, Raza and colleagues reviewed data from 214 adults who underwent BLVR at a single center between January 2018 ...
Virginia’s probe into public universities’ displacement of Black neighborhoods no longer theoretical
A Newport News task force revealed its preliminary findings in a recent meeting, the most public update yet in a process many ...
Adults with atrial fibrillation who drank a cup a day of caffeinated coffee were less likely to have recurrent AF or atrial ...
Kim was one of a dozen graduate students, each from a different school at the U, who competed in Three Minute Thesis, an ...
SAN DIEGO, Nov. 15, 2025 /PRNewswire/ — BrainXell, Inc. today announced that data will be presented during poster sessions at ...
In other words, we can use AI as a simulated audience: a stand-in that reacts to a data story as if it were a specific type ...
Arcitecta, a creative and innovative data management software company, will participate at SC25 in St. Louis, Missouri, November 16-21, featuring a visually immersive booth where research, creativity ...
ERS 2025 covered lung cancer treatment advances like robot-assisted bronchoscopy with integrated cone-beam CT (RAB-CBCT) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback